Reactivation of Herpes Zoster Keratitis Following Shingrix Vaccine

We present a case of herpes zoster keratitis reactivation shortly following the Shingrix vaccine. In our patient, reactivation of herpes zoster keratitis occurred a few weeks following the herpes zoster subunit (HZ/su) vaccine. The development of herpes zoster ophthalmicus following HZ/su is exceedi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Tracy J., Ta, Christopher N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958576/
https://www.ncbi.nlm.nih.gov/pubmed/35431886
http://dx.doi.org/10.1159/000522272
_version_ 1784676973367263232
author Lu, Tracy J.
Ta, Christopher N.
author_facet Lu, Tracy J.
Ta, Christopher N.
author_sort Lu, Tracy J.
collection PubMed
description We present a case of herpes zoster keratitis reactivation shortly following the Shingrix vaccine. In our patient, reactivation of herpes zoster keratitis occurred a few weeks following the herpes zoster subunit (HZ/su) vaccine. The development of herpes zoster ophthalmicus following HZ/su is exceedingly rare, with only one prior reported case found in the literature. Reporting of this potential correlation is important in understanding the full risks of vaccines and can help elucidate the etiology of such responses.
format Online
Article
Text
id pubmed-8958576
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-89585762022-04-14 Reactivation of Herpes Zoster Keratitis Following Shingrix Vaccine Lu, Tracy J. Ta, Christopher N. Case Rep Ophthalmol Case Report We present a case of herpes zoster keratitis reactivation shortly following the Shingrix vaccine. In our patient, reactivation of herpes zoster keratitis occurred a few weeks following the herpes zoster subunit (HZ/su) vaccine. The development of herpes zoster ophthalmicus following HZ/su is exceedingly rare, with only one prior reported case found in the literature. Reporting of this potential correlation is important in understanding the full risks of vaccines and can help elucidate the etiology of such responses. S. Karger AG 2022-02-24 /pmc/articles/PMC8958576/ /pubmed/35431886 http://dx.doi.org/10.1159/000522272 Text en Copyright © 2022 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Lu, Tracy J.
Ta, Christopher N.
Reactivation of Herpes Zoster Keratitis Following Shingrix Vaccine
title Reactivation of Herpes Zoster Keratitis Following Shingrix Vaccine
title_full Reactivation of Herpes Zoster Keratitis Following Shingrix Vaccine
title_fullStr Reactivation of Herpes Zoster Keratitis Following Shingrix Vaccine
title_full_unstemmed Reactivation of Herpes Zoster Keratitis Following Shingrix Vaccine
title_short Reactivation of Herpes Zoster Keratitis Following Shingrix Vaccine
title_sort reactivation of herpes zoster keratitis following shingrix vaccine
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958576/
https://www.ncbi.nlm.nih.gov/pubmed/35431886
http://dx.doi.org/10.1159/000522272
work_keys_str_mv AT lutracyj reactivationofherpeszosterkeratitisfollowingshingrixvaccine
AT tachristophern reactivationofherpeszosterkeratitisfollowingshingrixvaccine

Ejemplares similares